RIL
DFTX

Rothschild Investment LLC’s Definium Therapeutics DFTX Stock Holding History

Rothschild Investment LLC’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$47K Buy
999
+707
+242% +$17.5K ﹤0.01% 1267
2026
Q1 		$5.52K Buy
292
+5
+2% +$85 ﹤0.01% 2003
2025
Q4 		$3.84K Buy
287
+14
+5% +$173 ﹤0.01% 2029
2025
Q3 		$3.22K Hold
273
– – ﹤0.01% 1942
2025
Q2 		$1.77K Buy
273
+270
+9,000% +$1.78K ﹤0.01% 2153
2025
Q1 		$18 Hold
3
– – ﹤0.01% 3008
2024
Q4 		$21 Hold
3
– – ﹤0.01% 2937
2024
Q3 		$17 Hold
3
– – ﹤0.01% 2881
2024
Q2 		$22 Hold
3
– – ﹤0.01% 2797
2024
Q1 		$28 Hold
3
– – ﹤0.01% 2254
2023
Q4 		$11 Buy
+3
New +$9 ﹤0.01% 1345

Other funds holding DFTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Rothschild Investment LLC's DFTX Position: Q2 2026 in Review

Rothschild Investment LLC increased its Definium Therapeutics (DFTX) stake by 242% in Q2 2026, buying an estimated $17.5K and bringing the position to 999 shares worth $47K. The position accounts for ﹤0.01% of the portfolio, ranked #1267.

Rothschild Investment LLC first reported a position in DFTX in Q4 2023 and has held it in 11 quarters since. 129 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

  • Rothschild Investment LLC held 999 shares of Definium Therapeutics worth $47K as of Q2 2026.
  • Rothschild Investment LLC bought 707 Definium Therapeutics shares in Q2 2026, an estimated $17.5K.
  • Definium Therapeutics made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #1267 holding.
  • Rothschild Investment LLC first reported a position in Definium Therapeutics in Q4 2023 and has held it in 11 quarters since.
  • 129 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.